Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49,761 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Chinese Expert Consensus on Management of Special Adverse Effects 
Associated with Lorlatinib].
Zhou Q, Lu S, Li Y, Jia F, Li G, Hong Z, Lu Y, Fan Y, Zhou J, Liu Z, Li J, Wu YL; Chinese Thoracic Oncology Group (CTONG); Chinese Expert Consensus on Management of Special Adverse Effects Associated with Lorlatinib Workgroup. Zhou Q, et al. Among authors: li y, li j, li g. Zhongguo Fei Ai Za Zhi. 2022 Aug 20;25(8):555-566. doi: 10.3779/j.issn.1009-3419.2022.101.39. Zhongguo Fei Ai Za Zhi. 2022. PMID: 36002192 Free PMC article. Chinese.
Effects of memantine on clinical ratings, fluorodeoxyglucose positron emission tomography measurements, and cerebrospinal fluid assays in patients with moderate to severe Alzheimer dementia: a 24-week, randomized, clinical trial.
Wang T, Huang Q, Reiman EM, Chen K, Li X, Li G, Lin Z, Li C, Xiao S. Wang T, et al. Among authors: li c, li g, li x. J Clin Psychopharmacol. 2013 Oct;33(5):636-42. doi: 10.1097/JCP.0b013e31829a876a. J Clin Psychopharmacol. 2013. PMID: 23948786 Clinical Trial.
49,761 results
You have reached the last available page of results. Please see the User Guide for more information.